ArticleMaterials today. Proceedings2021
Functionality of nanomaterials and its technological aspects - Used in preventing, diagnosing and treating COVID-19.
Article in Materials today. Proceedings, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Updates on the Biofunctionalization of Gold Nanoparticles for the Rapid and Sensitive Multiplatform Diagnosis of SARS-CoV-2 Virus and Its Proteins: From Computational Models to Validation in Human Samples.International journal of molecular sciences · 2023Review
- A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS - CoV- 2 (COVID - 19).Journal of molecular liquids · 2022Review
- Rapid and efficient testing of the toxicity of graphene-related materials in primary human lung cells.Scientific reports · 2022Article
- Metal Nanoparticles and Carbon-Based Nanomaterials for Improved Performances of Electrochemical (Bio)Sensors with Biomedical Applications.Materials (Basel, Switzerland) · 2021Review
- Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives.International journal of nanomedicine · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 (Coronavirus) has severely affected the life of human beings since December 2019. Many difficulties are faced by human beings to prevent the spread of the corona virus. However, this unexpected evolution of COVID-19 has also thrown many challenges to scientists and researchers so as to develop technologies that can be used to combat COVID-19. In the effort to combat COVID-19, many research universities and academic laboratories are also contributing by developing many technologies like Facing masks, hand sanitizers, hand washing machines, etc., to control and prevent the spread of COVID-19 disease. The use of Nano-materials is proving to be very effective in prevention, detection and diagnosis of COVID-19. In this paper many such technologies that are used to combat COVID-19 are also discussed. Some of the technologies like the germ trap technology used in face masks and hoods are also discussed. The use of nano-coatings, nano materials like graphene and carbon nano materials is playing a key role in preventing the spread of the virus. Antimicrobial nano-materials like silver nanoparticles are also effectively contributing to preventing the spread of the virus. Nano bio-sensors and gold nanoparticles are used in RT-PCR (Reverse transcription polymerase chain reaction) testing devices which are used for detection of coronavirus. The use of many nano chemicals and compounds has helped in making vaccines and anti-viral drugs that are today showing a way to safeguard human beings against the attack of this deadly virus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.